How Often Should Women Get a Cervical Screening?

Cervical cancer is one of the most preventable cancers. Screening has reduced mortality dramatically in countries with organised programmes — the UK’s programme has cut incidence by about 70% since its introduction. Yet it remains one of the screenings most commonly missed or delayed.

Part of the confusion is that the guidance has changed in recent years. Many countries have moved from Pap smears to HPV testing, which works differently and allows longer intervals between tests. If your schedule seems to have shifted, that’s likely why.

What cervical screening detects

Cervical screening doesn’t test for cancer directly. It tests for abnormal cell changes — and, in more recent programmes, for the human papillomavirus (HPV) that causes the vast majority of cervical cancers.

HPV is extremely common. Most sexually active people will carry it at some point, and in most cases the immune system clears it without intervention. Cervical cancer typically develops when a high-risk strain of HPV persists for years and causes cell changes that are left undetected and untreated. This slow progression is exactly what makes screening so effective: there’s a long window in which abnormalities can be caught and managed before cancer develops.

Starting age: why not before 25?

Most programmes start at 25, with the US beginning at 21. Starting earlier is a deliberate choice, not an oversight.

In younger adults, HPV infections are common and the immune system usually resolves them without any lasting change. Screening too early picks up transient infections and minor cell abnormalities that would self-resolve — leading to unnecessary follow-up, anxiety, and in some cases treatment that carries its own risks. The evidence across multiple countries consistently shows that screening under 25 does not reduce cervical cancer mortality, but does increase the rate of unnecessary procedures.

This is a specific application of a broader principle: the interval between screenings exists for a reason, and testing more often — or earlier — doesn’t always mean catching more disease. It often means catching more normal variation.

What guidelines say by country

Country / Region	Test used	Starting age	Frequency	Authority
United States	Pap smear every 3 years, OR HPV co-test every 5 years	21	Every 3 years (Pap) or every 5 years (co-test)	USPSTF (2018)
United Kingdom	HPV test	25	Every 3 years (25–49); every 5 years (50–64)	NHS
Canada	Pap smear	25	Every 3 years after two normal annual tests	CTFPHC (2013, under review)
Australia	HPV test	25	Every 5 years	National Cervical Screening Program
Europe (most programmes)	Pap or HPV test	25	Every 3–5 years	EC / national bodies

Guidelines vary by country — check with your local health authority.

Why the test type and interval differ

The shift from Pap smears to HPV testing in several countries reflects a genuine advance in screening science — and it’s the main reason intervals have lengthened.

Pap smear vs HPV test. A Pap smear (cervical smear) looks directly for abnormal cells. An HPV test looks for the virus that causes those changes. HPV testing is more sensitive — it’s better at detecting high-risk HPV before cell changes have occurred. This earlier detection means a negative HPV test provides stronger reassurance for a longer period, which is why HPV-based programmes can safely extend intervals from 3 to 5 years.

Australia’s 2017 programme change. Australia moved from a 2-yearly Pap smear to a 5-yearly HPV test in December 2017. This looks like a dramatic reduction in screening frequency, but the evidence showed the 5-year HPV test programme provides equal or better protection against cervical cancer than 2-yearly Pap smears, with fewer unnecessary procedures. Longer intervals with a better test can outperform more frequent testing with a less sensitive one.

The US offers a choice. Current USPSTF guidelines give women two options: Pap smear every 3 years from age 21, or Pap plus HPV co-test every 5 years from age 30. Both are considered equivalent in protective value. The choice reflects patient and provider preference, and the fact that not all providers have transitioned fully to HPV-based testing.

Canada’s guidelines are under review. The CTFPHC 2013 guideline (Pap every 3 years from 25) is being updated. Given international trends toward HPV-based testing, the update is expected to address this transition.

After abnormal results

A single abnormal screening result doesn’t mean cancer — in most cases it means the programme has picked up exactly what it’s designed to detect. Follow-up typically involves a repeat test at a shorter interval, or referral for colposcopy (a closer examination of the cervix) if cell changes look more significant.

If follow-up shows the changes have resolved — as they often do — you return to the normal screening schedule. If further management is needed, it’s typically a minor procedure with high success rates.

HPV vaccination and screening

HPV vaccination, offered in many countries to adolescents, reduces the risk of the strains responsible for most cervical cancers. Vaccinated individuals still need cervical screening — the vaccines don’t cover all high-risk strains, and the vaccination programme has only reached some of the adults now being screened. Vaccination and screening work in combination.

For a broader view of where cervical screening fits alongside other preventive checks for women — including mammography and blood tests — the adults’ health screening guide covers the full schedule by decade.

Frequently Asked Questions

How often should I get a cervical screening (smear test)?

It depends on your country and the test being used. In the UK, every 3 years from age 25 to 49, then every 5 years from 50 to 64. In the US, every 3 years from age 21 with a Pap smear, or every 5 years from age 30 with an HPV co-test. In Australia, every 5 years from age 25 using an HPV test. Always follow the interval set by your national programme — the gaps are based on evidence, not convenience.

Why has the interval between cervical screenings gotten longer in some countries?

Many countries have switched from Pap smears to HPV testing, which is more sensitive. A negative HPV test provides stronger reassurance that the cervix is clear for a longer period, allowing safe extension of the interval from 3 to 5 years. Australia made this switch in 2017 and evidence shows the 5-yearly HPV programme provides equivalent protection to 2-yearly Pap smears.

Why does cervical screening start at 25 in most countries, but 21 in the US?

HPV infections are very common in younger adults and usually clear without causing lasting changes. Starting screening at 21 or 25 rather than earlier reflects evidence that screening before this age picks up transient infections and minor abnormalities that would self-resolve — leading to unnecessary procedures without reducing cancer mortality. The USPSTF starts at 21; most other national programmes start at 25.

I've had the HPV vaccine — do I still need cervical screening?

Yes. HPV vaccines protect against the most common high-risk strains but not all of them. Many adults receiving cervical screening now were vaccinated as teenagers, but some were not, and the vaccines have only been available for a relatively short time. Screening and vaccination work together — getting the vaccine doesn't remove the need for regular cervical screening.

What happens if my result comes back abnormal?

An abnormal result means the programme has detected what it was designed to find — usually cell changes or HPV that warrant monitoring or further investigation. Most abnormal results don't indicate cancer. You'll typically be asked to return for a shorter-interval repeat test or referred for colposcopy, a more detailed examination. Many abnormalities resolve on their own; others are managed with a minor procedure.

Cervical screening is one of those checks where knowing exactly when you’re due — and not losing track between the 3 or 5-year gaps — makes a real difference. Screening Clearing is a free iOS and Android app for tracking your personal health screening schedule, including cervical screening reminders tailored to your age and last test date.